Leerink Partnrs Issues Positive Estimate for KYMR Earnings
Kymera Therapeutics, Inc. (NASDAQ:KYMR – Free Report) – Equities researchers at Leerink Partnrs increased their Q2 2025 earnings estimates for Kymera Therapeutics in a research report issued to clients and investors on Monday, June 2nd. Leerink Partnrs analyst F. Khurshid now expects that the company will post earnings per share of ($1.08) for the quarter, […]
Kymera Therapeutics, Inc. (NASDAQ:KYMR – Free Report) – Equities researchers at Leerink Partnrs increased their Q2 2025 earnings estimates for Kymera Therapeutics in a research report issued to clients and investors on Monday, June 2nd. Leerink Partnrs analyst F. Khurshid now expects that the company will post earnings per share of ($1.08) for the quarter, […]
